These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 24048085)
1. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Leung JM; Olivier KN Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014. Adjemian J; Olivier KN; Prevots DR Ann Am Thorac Soc; 2018 Jul; 15(7):817-826. PubMed ID: 29897781 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Binder AM; Adjemian J; Olivier KN; Prevots DR Am J Respir Crit Care Med; 2013 Oct; 188(7):807-12. PubMed ID: 23927602 [TBL] [Abstract][Full Text] [Related]
4. Clinical course and significance of nontuberculous mycobacteria and its subtypes in cystic fibrosis. Eikani MS; Nugent M; Poursina A; Simpson P; Levy H BMC Infect Dis; 2018 Jul; 18(1):311. PubMed ID: 29980189 [TBL] [Abstract][Full Text] [Related]
11. Nontuberculous mycobacteria in cystic fibrosis patients on the Island of Gran Canaria. A population study. Campos-Herrero MI; Chamizo FJ; Caminero JA; Gilarranz R; Cabrera G; Cuyás J J Infect Chemother; 2016 Aug; 22(8):526-31. PubMed ID: 27262751 [TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward. Martiniano SL; Davidson RM; Nick JA Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and drug resistance of mycobacteria in Turkish cystic fibrosis patients. Satana D; Erkose-Genc G; Tamay Z; Uzun M; Guler N; Erturan Z Ann Clin Microbiol Antimicrob; 2014 Aug; 13():28. PubMed ID: 25123237 [TBL] [Abstract][Full Text] [Related]
15. Helping map the taxonomical position of the Nontuberculous Mycobacteria (NTM) in cystic fibrosis. Moore JE; Millar BC Int J Mycobacteriol; 2022; 11(3):303-308. PubMed ID: 36260450 [TBL] [Abstract][Full Text] [Related]
16. Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis. Park IK; Olivier KN Semin Respir Crit Care Med; 2015 Apr; 36(2):217-24. PubMed ID: 25826589 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study. Máiz L; Girón R; Olveira C; Vendrell M; Nieto R; Martínez-García MA BMC Infect Dis; 2016 Aug; 16(1):437. PubMed ID: 27549788 [TBL] [Abstract][Full Text] [Related]
18. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Mussaffi H; Rivlin J; Shalit I; Ephros M; Blau H Eur Respir J; 2005 Feb; 25(2):324-8. PubMed ID: 15684298 [TBL] [Abstract][Full Text] [Related]